Rafferty Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
Rafferty Asset Management's KYNB Position: Q3 2023 in Review
Rafferty Asset Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 14,520 shares — an estimated $980K sold.
Rafferty Asset Management first reported a position in KYNB in Q1 2019 and held it in 18 quarters. The position peaked at $5.49M in Q2 2019. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.
- Rafferty Asset Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
- Rafferty Asset Management sold 14,520 Kyntra Bio shares in Q3 2023, an estimated $980K.
- Rafferty Asset Management first reported a position in Kyntra Bio in Q1 2019 and held it in 18 quarters.
- Rafferty Asset Management's Kyntra Bio position peaked at $5.49M in Q2 2019.
- 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.
Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.